The Venture Codex Logo

The Venture Codex

Overview

Invests in biotech to disrupt drug development and patient treatment.

Founded

2007

Deals · 12mo

0

Stage focus

Series A

Geographic focus

United Kingdom
United States

Sector focus

Finance
Financial Services
Venture Capital

Investment portfolio

7rounds
NAMEDATESIZE
Kincell Bio
May 2025Led
$22 MOther Equity
EnteroBiotix
Apr 2024Participated
$34 MOther Equity
Kincell Bio
Jul 2023Led
$36 MOther Equity
eXmoor Pharma
May 2023Led
$35 MSeries A
Experic
Nov 2022Participated
$14 MSeries B
Inceptor Bio
May 2022Led
$37 MSeries A
EnteroBiotix
Sep 2021Participated
$21 MSeries A
Kincell Bio
May 2025Led
$22 MOther Equity
EnteroBiotix
Apr 2024Participated
$34 MOther Equity
Kincell Bio
Jul 2023Led
$36 MOther Equity
eXmoor Pharma
May 2023Led
$35 MSeries A
Experic
Nov 2022Participated
$14 MSeries B
Inceptor Bio
May 2022Led
$37 MSeries A
EnteroBiotix
Sep 2021Participated
$21 MSeries A
7
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Kineticos Ventures: 7 funding rounds are recorded in the selected participation categories.All available history.
Kineticos Ventures: 7 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A21
Series B01
Other Equity21

Monthly Deal Activity

Kineticos Ventures: 7 deals are recorded across 62 months.All available history.
Kineticos Ventures: 7 deals are recorded across 62 months. All available history
MonthDeals
Sep '211
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '221
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '221
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '231
Jun '230
Jul '231
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '241
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '251
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Kineticos Ventures: Health & Life Sciences is the largest displayed sector by deal count (7 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Kineticos Ventures: Health & Life Sciences is the largest displayed sector by deal count (7 deals). All available history
SectorDeals
Health & Life Sciences7
Manufacturing1

Deal Size Distribution

Kineticos Ventures: 7 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Kineticos Ventures: 7 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M3
$25M-$50M4
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Kineticos Ventures: United States has the largest recorded deal count among the displayed regions (4 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Kineticos Ventures: United States has the largest recorded deal count among the displayed regions (4 deals). All available history
RegionDeals
United States4
Europe3
Kineticos Ventures: 8 co-investors are shown, with Scottish Enterprise sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Kineticos Ventures: 8 co-investors are shown, with Scottish Enterprise sharing 2 recorded deals. All available history
Co-investorShared deals
Scottish Enterprise2
Thairm Bio2
East Seattle Partners1
Harro Höfliger Packaging Systems1
MVM Partners1
NewSpring Capital1
Scottish National Investment Bank1
SIS Ventures1

Investment Strategy

Kineticos Ventures: Led accounts for 57% and participating for 43% of round participation.All available history.
Kineticos Ventures: Led accounts for 57% and participating for 43% of round participation. All available history
CategoryDeals (count)Share (%)
Led457%
Participating343%
Kineticos Ventures: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Kineticos Ventures: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead250%
Co-led250%

Team

Frank Lis

President and CEO

Shailesh Maingi

Founder & Exec Chair